Tpharm.info


Remicade package insert





Official Website for REMICADE (infliximab)

7/15/2014
01:36 | Author: Emma Coleman

Ambien package insert
Official Website for REMICADE (infliximab)

Learn about treatment with REMICADE (infliximab) across all uses and see Important Capitalized product names are trademarks of Janssen Biotech, Inc.

Download a doctor discussion guide to help you talk to your doctor about your plaque psoriasis symptoms.

Learn about the proven results of REMICADE treatment.

Hear from people who are living with—and doctors who are treating— moderay to severely active ulcerative colitis.

Learn about the proven results of REMICADE treatment.

Hear from people who are living with—and doctors who are treating— moderay to severely active Crohn’s disease.

You are now leaving.

This site is published by Janssen Biotech, Inc., which is solely responsible for its contents.

Comments (1)Read more



REMICADE (Janssen Biotech, Inc.) FDA Package Insert

5/14/2014
03:32 | Author: Emma Coleman

Fluzone package insert
REMICADE (Janssen Biotech, Inc.) FDA Package Insert

Janssen Biotech, Inc.: REMICADE is a tumor necrosis factor (TNF) blocker indicated for: Crohn's Disease (1.1): reducing signs and symptoms.

The risks and benefits of treatment with REMICADE should be carefully considered prior to initiating therapy in patients with chronic or recurrent infection.

REMICADE is indicated for the treatment of adult patients with chronic severe (i.e., extensive and/or disabling) plaque psoriasis who are candidates for systemic therapy and when other systemic therapies are medically less appropriate. REMICADE should only be administered to patients who will be closely monitored and have regular follow-up visits with a physician [see Boxed Warnings, Warnings and Precautions (5) ]

Within the ‘Prescription Medications’ section:

The URL of this page is: /lib/rx/meds/remicade/

The recommended dose of REMICADE is 3 mg/kg given as an intravenous induction regimen at 0, 2 and 6 weeks followed by a maintenance regimen of 3 mg/kg every 8 weeks thereafter for the treatment of moderay to severely active rheumatoid arthritis.

Comments (2)Read more

Remicade (Infliximab) Drug Information Indications, Dosage and

3/13/2014
05:48 | Author: David Perry

Fluzone package insert
Remicade (Infliximab) Drug Information Indications, Dosage and

Learn about indications, dosage and how it is supplied for the drug Remicade (Infliximab).

REMICADE is indicated for the treatment of adult patients with chronic severe (i.e., extensive and/or disabling) plaque psoriasis who are candidates for systemic therapy and when other systemic therapies are medically less appropriate. REMICADE should only be administered to patients who will be closely monitored and have regular follow-up visits with a physician [see BOXED WARNINGS, WARNINGS AND PRECAUTIONS ]

"The U.S. Food and Drug Administration today approved the first generic versions of Celebrex (celecoxib) capsules, a treatment for rheumatoid arthritis, osteoarthritis, short-term (acute) pain, and other conditions.

Comments (3)Read more

Drug Safety Labeling Changes Remicade (inflximab) IV Infusion

11/22/2014
03:16 | Author: Lauren Ross

Fluzone package insert
Drug Safety Labeling Changes Remicade (inflximab) IV Infusion

Remicade (inflximab) IV Infusion WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections.

Summary of Changes to Contraindications and Warnings BOXED WARNING WARNINGS ADVERSE REACTIONS MEDICATION GUIDE BOXED WARNING WARNINGS ADVERSE REACTIONS MEDICATION GUIDE.

Summary View.

Page Last Updated: 06/19/2009 Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.

Comments (0)

Infliximab Drug Information, Professional

9/21/2014
01:40 | Author: David Perry

Fluzone package insert
Infliximab Drug Information, Professional

Commonly used brand name(s): Remicade. Another.. References. Remicade package insert (Centocor—US), New 8/12/98, Rec 9/24/98.

provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.

†Not commercially available in Canada.

Developed: 05/05/1999 Revised: 01/30/2003 More FDA updates... More.

Data sources include Micromedex (updated Sep 26th, 2014), Cerner Multum (updated Oct 16th, 2014), Wolters Kluwer (updated Oct 9th, 2014) and others. To view content sources and attributions, refer to our editorial policy.

We comply with the HONcode standard for trustworthy health information. Verify here.

Terms of Use · Privacy Policy.

1 Not included in Canadian product labeling.

Follow: Google+ Facebook Twitter YouTube RSS.

Comments (0)